Across
- 6. Major perioperative concern in bulbar dysfunction.
- 7. Syndrome associated with small-cell lung cancer.
- 8. Protein that forms plaques in Alzheimer disease.
- 11. Autosomal dominant disorder characterized by chorea.
- 12. Progressive loss of cognitive function.
- 13. Protein forming neurofibrillary tangles.
- 14. Glutamate antagonist used to treat ALS.
- 15. CNS lesions characteristic of multiple sclerosis.
- 17. Most effective medication for Parkinson disease.
- 20. Autoimmune CNS disease causing demyelination.
- 21. Protein absent in Duchenne muscular dystrophy.
- 22. Depolarizing neuromuscular blocker generally avoided in many neuromuscular disorders.
- 23. Most common cause of dementia after age 65.
- 24. Neurotransmitter depleted in Parkinson disease.
- 26. Treatment that removes pathogenic antibodies from the blood.
- 28. Involuntary movement seen in Huntington disease.
- 30. Therapy using intravenous immunoglobulins.
- 31. Dangerous complication of succinylcholine in denervated muscle.
- 32. Free-radical scavenger used in ALS.
Down
- 1. Acute inflammatory polyneuropathy with ascending paralysis.
- 2. Neurodegenerative disease with resting tremor, rigidity, and akinesia.
- 3. MAO-B inhibitor used in Parkinson disease
- 4. Clinical sign associated with Duchenne muscular dystrophy.
- 5. Common autonomic problem in Guillain-Barre syndrome.
- 9. Common mediastinal tumor associated with myasthenia gravis.
- 10. Common cholinesterase inhibitor used for Alzheimer disease.
- 12. Childhood muscular dystrophy caused by absent dystrophin.
- 16. Neurotransmitter reduced in Alzheimer disease.
- 18. Drooping eyelid commonly seen in myasthenia gravis.
- 19. Also known as Lou Gehrig disease.
- 20. Autoimmune disorder targeting acetylcholine receptors.
- 21. Hallmark pathologic process in multiple sclerosis.
- 25. NMDA receptor antagonist used for Alzheimer disease.
- 27. Reversal agent considered safe in ALS.
- 29. Milder dystrophin-related muscular dystrophy.